Soluble CD163 predicts outcome in both chemoimmunotherapy and targeted therapy-treated mantle cell lymphoma.
Nikkarinen A, Lokhande L, Amini RM, Jerkeman M, Porwit A, Molin D, Enblad G, Kolstad A, Räty R, Hutchings M, Weibull CE, Hollander P, Ek S, Glimelius I.
Nikkarinen A, et al. Among authors: weibull ce.
Blood Adv. 2023 Sep 26;7(18):5304-5313. doi: 10.1182/bloodadvances.2023010052.
Blood Adv. 2023.
PMID: 37389827
Free PMC article.